Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qin Wan has a total of 165 co-authors. Here are the top co-authors by number of shared publications:

  • Yue-Yang Zhang

    Department of Endocrinology and Metabolism, Affiliated Hospital of Southwest Medical University, Luzhou, China

    11 shared publications
  • Bing-Xue Chen

    Department of Ultrasound Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China

    6 shared publications
  • Yu Wang

    Department of Cardiology, Luzhou People’s Hospital, Luzhou, China

    6 shared publications
  • Jie Lin

    Department of Endocrinology and Metabolism, Affiliated Hospital of Southwest Medical University, Luzhou, China

    5 shared publications
  • Ying Miao

    Department of Endocrinology and Metabolism, Affiliated Hospital of Southwest Medical University, Luzhou, China

    5 shared publications
  • Jing Gui

    Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, China

    4 shared publications

Latest Publications

  • Open Access

    Causal relationship between educational attainment and complications of Type 2 diabetes: Mendelian randomization study

    by WeiTao Han, Qin Wan

    Educational attainment (EA) is a critical metric for evaluating individual socioeconomic status, as it significantly impacts mortality rates and the occurrence of various diseases. This study aims to investigate the causal relationship between education and complications associated with type 2 diabetes mellitus, while also examining potential mediating pathways. To assess the causal relationship between EA and specific complications of type 2 diabetes, this study employs univariable Mendelian randomization (UVMR). Throughout this analysis, single nucleotide polymorphisms are utilized as genetic tools, thereby minimizing confounding and bias arising from reverse causation. With each 4.2-year increase in EA, patients with type 2 diabetes exhibit a reduced risk of type 2 diabetes mellitus with neurological complications (DNC) (0.33; 0.20, 0.54), type 2 diabetes with ophthalmic complications (DOC) (0.57; 0.41, 0.80), type 2 diabetes with peripheral circulatory complications (DPCC) (0.60; 0.39, 0.93), and type 2 diabetes with renal complications (DRC) (0.47; 0.32, 0.69). Among the 27 candidate mediators, body mass index, waist circumference, and watching television showed relatively large mediation proportion point estimates for some outcomes. The findings of this study suggest that EA exerts a causally protective effect on DNC, DOC, DPCC, and DRC. The candidate mediating pathways warrant further investigation because their independent contributions have not been established.

  • Open Access

    Causal effects of antihypertensive drugs on thyroid diseases

    by Xiao-Hong Wang, Yue-Yang Zhang, Qin Wan

    Thyroid disorders frequently coexist with cardiovascular disease, including hypertension, but whether long-term modulation of antihypertensive drug targets influences thyroid disease risk remains uncertain. We aimed to evaluate the associations of 7 antihypertensive drug-target classes with thyroid diseases in European and East Asian populations using a trans-ancestry drug-target Mendelian randomization (MR) framework. We performed a two-sample, trans-ancestry drug-target MR analysis of 7 antihypertensive target classes. Target-proximal single-nucleotide polymorphisms associated with systolic blood pressure (SBP) were used as genetic proxies. Estimates were scaled per 1-mm Hg genetically predicted increase in SBP; the putative effect of target inhibition that lowers SBP was therefore interpreted in the opposite direction. Summary statistics were obtained for 4 primary thyroid diseases, benign thyroid tumors where available, and 3 thyroid-related proteins in European and East Asian datasets. Hypertension was used as a positive-control outcome. Random-effects inverse-variance weighting was the primary method, with Wald ratio estimation for single-nucleotide polymorphism instruments and weighted-median, Cochran’s Q , MR-Egger, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier analyses as sensitivity assessments. Within the European populace, genetic surrogates for β-blockers exhibit (odds ratio = 0.93; 95% confidence interval = 0.87–0.99) a close association with heightened susceptibility to thyroid carcinoma, whereas KCNH2 (1.15; 1.01–1.32) demonstrates an inverse correlation with thyroid cancer risk. Moreover, calcium channel blockers exhibit a conspicuous linkage with an elevated incidence of hyperthyroidism (0.97; 0.96–0.99) alongside a diminished likelihood of thyroid cancer (1.07; 1.03–1.10). CYP17A1 exerts a protective influence against hyperthyroidism (1.04; 10.1–1.07) and Graves disease (1.10; 1.05–1.16) but manifests a pathogenic effect concerning hypothyroidism (0.99; 0.97–1.00) and thyroid cancer (0.92; 0.86–0.98). Conversely, KCNJ11 demonstrates a proximate correlation between diminished hypothyroidism risk and augmented thyroid cancer susceptibility (0.83; 0.73–0.95). Analogous estimations were noted for CYP17A1 within the East Asian cohort. Genetically proxied perturbation of several antihypertensive drug targets was associated with thyroid disease risk, with CYP17A1 showing the broadest cross-ancestry pattern. These estimates reflect lifelong target-proximal genetic effects rather than the clinical effects of prescribed drugs and should be considered hypothesis-generating pending replication, pharmacoepidemiological studies, and randomized clinical trials.

  • Transformer-based models for predicting cardiovascular risk in Chinese adults: development and validation.

    by Qiuyu Cao, Xingkun Xu, Hong Lin, Yue Yin, Shengli Wu, Mian Li, Yu Xu, Shaoxin Li, Yuchen Xu, Huapeng Wei, et al.

    Traditional Cox proportional hazards models show suboptimal performance for cardiovascular disease (CVD) risk prediction in Chinese populations. Transformer-based deep learning models have demonstrated promise in clinical risk prediction. In this study, sex-specific transformer-based models (China-AIHeart) for 10-year CVD risk prediction among Chinese adults were developed and validated. The derivation cohort included 156 790 participants [34.6% men; mean [SD] age, 56.7 [8.9] years) without CVD from the China Cardiometabolic Disease and Cancer Cohort. External validation was conducted in two independent Chinese cohorts (Xinjiang and CHARLS). Transformer-based time-to-event prediction models were developed, including a full model (22 predictors) and a simplified model (15 predictors). Performance was compared with Cox models using identical predictors and established risk scores (China-PAR, PREVENT-ASCVD, and SCORE2 Asia-Pacific equations). China-AIHeart demonstrated good discrimination (C-statistic [95% confidence interval, CI]: .767 [.754-.779] in men; .780 [.769-.791] in women), calibration (calibration χ2: 14.806 in men; 9.326 in women; Brier score: .104 in men; .077 in women), and net clinical benefit in predicting CVD risk. Predicted event rates closely matched observed risks across strata. Compared with Cox models with identical predictors, China-AIHeart showed improved discrimination (ΔC-statistic [95% CI]: .027 [.025-.028] in men; .031 [.029-.033] in women) and reclassification (net reclassification index [95% CI]: .478 [.466-.492] in men; .560 [.551-.572] in women), and outperformed China-PAR, PREVENT-ASCVD, and SCORE2 Asia-Pacific equations. External validation demonstrated robust performance, with C-statistics of .781/.825 (men/women) and .748/.820 for the full and simplified models in the Xinjiang cohort, and .740/.771 for the simplified model in the CHARLS cohort. The transformer-based China-AIHeart models predicted 10-year CVD risk and outperformed traditional Cox-based approaches, providing a practical tool for risk stratification in Chinese adults.


  • Open Access

    The association between platelet-to-albumin ratio and diabetic peripheral neuropathy: A cross-sectional study in the Chinese population

    by Wenting Deng, Siqi Zhang, Yueyang Zhang, Qin Wan

    Introduction: The early prevention and diagnosis of diabetic complications are challenging, particularly for diabetic peripheral neuropathy (DPN), which progresses insidiously and irreversibly. Currently, reliable biomarkers associated with DPN are still limited. This study explored the association between the platelet-to-albumin ratio (PAR) and diabetic peripheral neuropathy in Chinese adults with type 2 diabetes mellitus(T2DM). Methods: This cross-sectional study included adult patients with T2DM enrolled in the metabolic management center (MMC) database at the Affiliated Hospital of Southwest Medical University between June 2018 and December 2023. Participants meeting the predefined eligibility criteria were classified into diabetic peripheral neuropathy (DPN) and non-diabetic peripheral neuropathy (non-DPN) groups. The association between PAR and DPN was evaluated using logistic regression models, with subgroup analyses and restricted cubic spline regression used to examine potential effect modification and dose–response relationships. Receiver operating characteristic (ROC) curve analysis was performed to assess the discriminative ability of PAR for identifying DPN. Results: Among 1,141 patients with T2DM, including 427 patients with DPN, PAR levels were significantly higher in the DPN group than in the non-DPN group ( P < 0.001). Univariate analysis showed that higher PAR (OR=1.282, 95% CI: 1.183–1.389, P < 0.001) significantly increased the prevalence of DPN. After adjusting for confounders, the platelet-to-albumin ratio (PAR) remained independently associated with DPN (OR = 1.158, 95% CI: 1.0511.276, P = 0.003). In subgroup analysis, no significant interaction was observed (all P for interaction > 0.05). The restricted cubic spline regression confirmed a positive linear association between PAR levels and DPN ( P = 0.001, P for nonlinearity = 0.986). Additionally, ROC analysis identified an optimal PAR cut-off value of 5.5971 for distinguishing patients with and without DPN. Conclusions: In patients with T2DM, higher platelet-to-albumin ratio(PAR) levels were associated with the prevalence of diabetic peripheral neuropathy. This association may be related to underlying inflammatory processes involved in DPN.


  • Open Access

    Genetically predicted causal association between type 2 diabetes and heart failure: A two-sample Mendelian randomization study

    by Xiaoyu Yang, Binlu Wang, Qin Wan

    The correlation between type 2 diabetes mellitus (T2DM) and heart failure has been extensively studied; however, the causal nature of this relationship remains a topic of debate. Our study employs a two-sample Mendelian randomization (MR) approach to rigorously examine the causal relationship between T2DM and heart failure. By utilizing summary statistics from genome-wide association studies (GWAS) involving 655,666 individuals for T2DM (including 61,714 cases and 1178 controls) and 977,323 individuals for heart failure (including 47,309 cases and 930,014 controls), we aimed to provide strong evidence for a causal association. The analysis revealed a significant causal relationship, with individuals with T2DM exhibiting a 7% increased odds of heart failure (inverse variance weighting [IVW]: OR = 1.07, 95% CI = 1.04–1.10, P = 1.07 × 10 −6 ). This finding highlights the significance of T2DM as an independent risk factor for heart failure and suggests that MR analysis could be a valuable tool for the early identification of heart failure risk in diabetic populations. Our results emphasize the need for enhanced screening and preventive measures for heart failure in patients with T2DM, potentially leading to improved patient outcomes through early diagnosis and intervention.

  • Open Access

    Association between the estimated glucose disposal rate and the occurrence of major cardiovascular events and stroke

    by Yue-Yang Zhang, Qin Wan

    The Estimated Glucose Disposal Rate (eGDR) recognised as a reliable biomarker for assessing insulin resistance. Accordingly, this study aims to investigate the potential association between eGDR and the occurrence of major adverse cardiovascular events (MACE) and stroke within a cohort of the Chinese population. The China Cardiometabolic Disease and Cancer Cohort Study is a large-scale, nationwide, multicenter prospective cohort study initiated in 2010. The study collected baseline data from 10,008 participants, with a subsequent 10-year follow-up period. Following the relevant inclusion and exclusion criteria, a total of 8,723 participants were included in the final analysis. Participants were stratified into four groups based on the quartiles of their eGDR levels. To better evaluate the association between eGDR and the risks of MACE and stroke, the study employed Cox proportional hazards models, restricted cubic splines (RCS), receiver operating characteristic curve(ROC), and subgroup analyses to ensure the robustness of the findings. A total of 438 MACE events and 445 stroke events were documented. Cox regression and RCS analyses demonstrated a negative association between eGDR and the risk of both MACE and stroke in fully adjusted models. Specifically, each one standard deviation increase in eGDR was associated with a 2% reduction in the risk of MACE and stroke. Moreover, compared with participants in the Q1 group, those in the Q4 group exhibited a significantly lower risk of primary outcomes. The RCS analysis identifies an optimal eGDR threshold of 9.92. Additionally, the ROC demonstrates that incorporating eGDR significantly enhances the diagnostic efficacy compared to the basic model and other positive controls. Elevated eGDR levels are associated with a lower risk of MACE and stroke among non-diabetic individuals in China.


  • Open Access

    TyG-BMI as a predictor of ischemic stroke over 10 years in middle-aged and older adults: findings from the China cardiometabolic disease and cancer cohort (4C) study

    by Ying Miao, Yu Wang, Yuting He, Pijun Yan, Qin Wan

    Background: Ischemic stroke (IS) is a leading cause of death and disability, imposing a significant economic burden globally. Research has demonstrated that insulin resistance (IR) plays a key role in the development of atherosclerosis, platelet dysfunction, and a hypercoagulable state, all of which contribute to the pathogenesis and progression of IS. The triglyceride-glucose (TyG) index serves as a practical tool for assessing insulin sensitivity, with previous studies exploring its correlation with IS. However, the relationship between the novel TyG-body mass index (TyG-BMI), which combines TyG with body mass index (BMI) as a measure of general obesity, and IS remains unclear. Therefore, this study employs a prospective design to assess the predictive value of TyG-BMI for the 10-year risk of IS in individuals without intervention.Methods: The study population was derived from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, predominantly comprising participants from Luzhou City, Sichuan Province, and primarily targeting individuals aged 40 and above. Comprehensive data collection was conducted using both questionnaires and specialized medical equipment, covering physical measurements, blood pressure, and relevant biochemical markers. Participants with a history of stroke were excluded from the study. Based on the initial data, participants were divided into four groups according to the TyG-BMI quartiles. Spearman correlation analysis was used to examine the relationship between TyG-BMI and clinical and laboratory parameters. The Log-rank test was applied to analyze differences in the cumulative incidence of IS among the four groups. The Cox proportional hazards model was used to analyze the relationship between TyG-BMI and the 10-year incidence of new IS. Additionally, the ROC curve was employed to assess the predictive value of TyG-BMI for the 10-year incidence of new IS in the middle-aged and elderly population.Results: This study included 9,406 participants, consisting of 3,139 males (33.4%) and 6,267 females (66.6%). During the non-interventional follow-up period of 10 years, 483 deaths were recorded, resulting in a mortality rate of 5.1%. In addition, 527 new cases of IS were reported, yielding an incidence rate of 5.6%. The Log-rank test revealed a significant increase in the cumulative incidence of IS across increasing TyG-BMI quartiles (p < 0.01). Furthermore, Cox regression analysis identified a significant correlation between TyG-BMI levels, as a risk factor, and the occurrence of IS. After adjusting for other risk factors, the risk of developing new IS in the Q2 group was 1.449 times that of the Q1 group (p = 0.012), while the risk in the Q3 group was 1.438 times that of the Q1 group (p = 0.014), and the risk in the Q4 group was 1.434 times that of the Q1 group (p = 0.020). ROC curve analysis showed that, in the overall study population, TyG-BMI demonstrated a predictive value for new IS over 10 years (AUC = 0.566, 95% CI = 0.542–0.590, p < 0.001), with a cutoff value of 204.1307, sensitivity of 64.3%, and specificity of 47.8%. In male participants, TyG-BMI showed a predictive value for new IS over 10 years (AUC = 0.537, 95% CI = 0.501–0.574, p = 0.067), with a cutoff value of 195.1996, sensitivity of 73.8%, and specificity of 37.0%. In female participants, TyG-BMI demonstrated a predictive value for new IS over 10 years (AUC = 0.583, 95% CI = 0.551–0.615, p < 0.001), with a cutoff value of 204.295, sensitivity of 65.8%, and specificity of 48.7%.Conclusion: This study revealed a significant association between TyG-BMI and the 10-year incidence of new-onset IS among middle-aged and elderly individuals, indicating that TyG-BMI may serve as a valuable predictive marker for assessing IS risk in this population.


  • Open Access

    Systematic regulation of circulating lipids, amino acids, and blood glucose to enhance the prevention of hyperthyroidism: A Mendelian randomization analysis

    by Xiao-Hong Mm Wang, Qin Mm Wan

    Several observational investigations have documented correlations between circulating metabolic biomarkers and hyperthyroidism; nevertheless, the implications of blood lipids, amino acids, and blood glucose in hyperthyroidism remain elusive. Employing summary-level data from the most recent large-scale genome-wide association study(N = 136,016) for 233 circulating metabolic biomarkers, along with data on hyperthyroidism from the R10 dataset released by the FinnGen consortium(N = 412,181), we performed a bidirectional two-sample Mendelian randomization (MR) analysis. We computed the impacts of both utilizing the inverse variance weighted, MR Egger, weighted median, simple mode, and weighted mode techniques, and evaluated the dependability of the findings utilizing Cochran Q test, MR-Egger intercept regression analysis, and MR-PRESSO. Subsequently, a reverse MR analysis was conducted on the circulating metabolic biomarkers identified to exhibit an association with hyperthyroidism in the forward MR analysis. The inverse variance-weighted analysis revealed that for each 1-standard deviation increase in alanine levels, glucose levels, and the cholesteryl esters to total lipids ratio in large very low-density lipoprotein particles, the risk of hyperthyroidism decreased by 14%, 19%, and 15%, respectively. The reverse MR analysis did not identify any significant effect of hyperthyroidism on circulating metabolic biomarkers. Alanine levels, glucose levels, cholesteryl esters to total lipids ratio in large very low-density lipoprotein levels, and the free cholesterol to total lipids ratio in large low-density lipoprotein levels were differentially associated with the risk of hyperthyroidism, and have the potential to be used as biomarkers of hyperthyroidism. The findings of this study may offer novel insights into the prevention and management of hyperthyroidism.

  • Open Access

    Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses

    by Yue-Yang Zhang, Bin-Lu Wang, Bing-Xue Chen, Qin Wan

    Background: In recent years, driven by the rapid advancement of proteomics research, numerous scholars have investigated the intricate associations between plasma proteins and various diseases. Thus, this study aimed to identify novel therapeutic targets for preventing and treating metabolic-related diseases through Mendelian randomization (MR). Methods: This study primarily utilized the MR method, leveraging genetic data from multiple large-scale publicly available genome-wide association studies. We employed two-sample MR within this framework to assess the associations between 1001 plasma proteins and 5 metabolism-related diseases. Finally, we strengthen the robustness and reliability of the MR results by conducting a series of sensitivity analyses, including bidirectional MR, colocalization analysis, Cochran’s Q test, and the MR-Egger intercept test. Results: The results from the inverse variance weighted method revealed that, following false discovery rate correction, many plasma proteins are significantly associated with metabolic-related diseases. Genetically predicted risks vary across diseases: for coronary artery disease, from 0.82 FGR proto-oncogene, Src family tyrosine kinase (FGR) to 1.13 (interleukin-6); for obesity, from 0.992 (POLR2F) to 1.005 (PRKAB1); for osteoporosis, from 0.998 (AIF1) to 1.001 (CLC); for stroke, from 0.71 (TNFRSF1A) to 1.47 (TGM2); and for type 2 diabetes, from 0.79 (KRT18) to 1.47 (RAB37). Conclusion: Our findings reveal numerous plasma proteins linked to metabolic-related diseases. These findings offer fresh insights into the etiology, diagnostics, and treatment of these conditions.